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INTRODUCTION
The rapid introduction of desflurane produces sympathet-
ic stimulation and associated changes, which are represent-
ed by increases in blood pressure, heart rate and pupil diam-
eter (1-3). The cerebrovascular response to a rapid increase
in desflurane was also reported and considered to be either a
coincident or independent change from hemodynamic stimu-
lation (4, 5). There are few reports on the cerebral oximetric
response to the introduction of desflurane. 
Hoffman et al. (6) observed an increase in the cerebral tis-
sue PO2 during desflurane anesthesia, and suggested the in-
creased PO2 to be indicative of the improved cerebral oxygena-
tion status. The cerebral oximetry (rSO2) values can be com-
pared with the focal cerebral tissue PO2. Moreover, the increase
in rSO2 can be regarded not only as an improvement in the
cerebral oxygenation status but also as a resultant hyperemia.
It was hypothesized that rSO2would also respond to the rapid
introduction of desflurane.
Carbon dioxide plays an important role in regulating the
cerebral blood flow. Hence, hypocapnia would be favorable
in desflurane-induced hyperemic changes to the brain. The
addition of N2O, which is commonly used in everyday prac-
tice of anesthesia, decreases the minimun alveolar concentra-
tion (MAC) of desflurane and would attenuate the response
of rSO2 by increasing the depth of anesthesia if the change
in rSO2 is dependent on systemic sympathetic stimulation.
This study examined the inherent cerebrovascular effects of
N2O. It is expected that this study will help to improve the
understanding of the cerebrovascular changes during desflu-
rane anesthesia.
Accordingly, in order to demonstrate that hypocapnia or
the addition of N2O can modify the response of rSO2, the con-
centration (dose)-response relationship for the change in rSO2
during the rapid introduction of desflurane was examined
using a nonlinear mixed-effects model in a grouped repeat-
ed design. 
MATERIALS AND METHODS
After obtaining institutional research board approval (2008-
1-26) and written informed consent, 12 American Society of
Anesthesiologist (ASA) physical status class 1-2 adults who
underwent a variety of surgical procedures requiring general
anesthesia were enrolled in this study. The exclusion criteria
included subjects with alleged respiratory, cardiovascular, and
cerebral diseases, or were taking associated medications. No
premedicament was given. The subjects were allocated ran-
domly to an Air (n=6) or N2O group (n=6).
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Hypocapnia Attenuates, and Nitrous Oxide Disturbs the Cerebral 
Oximetric Response to the Rapid Introduction of Desflurane
The aim of this study was to develop a nonlinear mixed-effects model for the increase
in cerebral oximetry (rSO2) during the rapid introduction of desflurane, and to deter-
mine the effect of hypocapnia and N2O on the model. Twelve American Society of
Anesthesiologist physical status class 1 and 2 subjects were allocated randomly
into an Air and N2O group. After inducing anesthesia, desflurane was then increased
abruptly from 4.0 to 12.0%. The PETCO2, PETDESF and rSO2 were recorded at 12 pre-
determined periods for the following 10 min. The maximum increase in rSO2 reached
+24-25% during normocapnia. The increase in rSO2 could be fitted to a four param-
eter logistic equation as a function of the logarithm of PETDESF. Hypocapnia reduced
the maximum response of rSO2, shifted the EC50 to the right, and increased the slope
in the Air group. N2O shifted the EC50 to the right, and reduced the slope leaving
the maximum rSO2 unchanged. The N2O-effects disappeared during hypocapnia.
The cerebrovascular reactivity of rSO2 to CO2 is still preserved during the rapid intro-
duction of desflurane. N2O slows the response of rSO2. Hypocapnia overwhelms
all the effects of N2O. 
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In addition to the standard monitoring equipment, the
emitter-sensor couplet of a cerebral oximeter (INVOS 5100B,
Somanetics
�, Troy, OH, U.S.A.) was attached to the right
brow, and a sensor from a Finometer (Finapres Medical Sys-
tems, Amsterdam, The Netherlands) was attached to the ap-
propriate finger to obtain the continuous arterial pressure,
heart rate, and cardiac output. The concentrations of CO2,
N2O and desflurane were measured using the airway mod-
ule embedded in an anesthesia machine (S/5 Avance, Datex-
Ohmeda, Helsinki, Finland). Anesthetic induction and main-
tenance were achieved as described by our institution’s stan-
dard anesthetic guidelines. Briefly, vecuronium (0.08-0.1 mg/
kg), remifentanil (computer-estimated effect-site concentra-
tion, Ce=3.0 ng/mL) were administered intravenously as re-
quired after confirming the loss of consciousness with a titrat-
ed dose of intravenous propofol (1.5-2.0 mg/kg). Remifentanil
was administered using a target-controlled infusion device
(Orchestra
� Base Primea, Fresenius-Kabi, Bad Homburg,
Germany). Desflurane (6.0% dial-concentration) were inhaled.
After the trachea was intubated, the infusion of remifentanil
was stopped and the dial-concentration of desflurane was ad-
justed to 4.0%. In the Air group, medical air was added to the
oxygen to ensure an inspired oxygen fraction of 0.4. N2O was
added in the N2O group. Mechanical ventilation was started
with VT=8 mL/kg and RR=10 breath/min while permitting
an inter-subjects difference in the end-tidal concentration of
CO2 (PETCO2). The corresponding PETCO2 was 33±4 (ranged
24-41) mmHg throughout the study period. The SpO2 values
were approximately 98-100% during the course of the study.
After stabilization for approximately 20 min until the Ce
of remifentanil fell to below 0.3, the average end-tidal (PET-
DESF) and inspired (PFIDESF) desflurane reached 4.0%, and the
dial-concentration of desflurane was increased to 12.0%, simul-
taneously with 6 L/min of a fresh gas flow rate and the PET-
DESF converged within 90% of the PFIDESF. This time was set
to time 0 (T0). 
Measurements and calculations
The basic preanesthetic measurements included the body
weight, height, rSO2, mean arterial pressure (MAP), heart
rate (HR), cardiac output (CO), body surface area (BSA), and
derived cardiac index (CI). Consecutive measurements, includ-
ing the rSO2, SpO2, MAP, HR, CI, PETDESF, PFIDESF, and PETCO2
were recorded at T0 and the following periods; 0.5, 1.0, 1.5,
2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 8.0, and 10 min from T0. The
measurement was stopped when the MAP>120 mmHg or
<50 mmHg, and the HR>130 beats/min or <45 beats/min.
However, the measurements before stopping were also in-
cluded in the analysis. Two subjects, one in the Air group
and one in the N2O group, showed hypotension (MAP<50
mmHg), which was treated promptly with intravenous ephe-
drine 5 mg. The  rSO2was defined as the difference between
the rSO2at a given time from rSO2at T0. The estimated alveo-
lar concentration of desflurane (PET/FIDESF) was defined and
calculated as the PETDESF divided by the final PFIDESF.
Reliability of the rSO2 measurements
By examining the variance components using a random
intercept and slope model, the reliability of the two rSO2
measurements was tested before and after the induction of
anesthesia. The value of rSO2 was predicted from hemoglobin
with a combination of the anesthesia-effect and subject-effect
as random effects. The intra-class correlation (ρ ) was defined
and estimated,
τ 2
ρ = τ 2+σ 2
where τis the between-subjects variance and σis the with-
in-subjects variance. The variance of the between-subjects
random effects was composed of the variance of each random
effect, in this case, τ 2=τ intercept2+τ slope2. Interpretation of ρwas
descriptive. A high ρ(>0.90) suggests that the between-sub-
jects component was dominant in the total variances, which
also indicated a good reliability of the repeated measurement
within-subjects.
Hemodynamic variables
The temporal changes in the MAP, HR, and CI were ana-
lyzed by an analysis of the covariance (ANCOVA). The AN-
COVA model was fitted as a function of time, and N2O was
used as a grouping variable. When the N2O-effect was signif-
icant, 12 pairwise comparisons were made at each time peri-
od using the adjusted P according to the Dunn-Sidak pro-
cedures (P′ =1-[1-P]12).
Modeling for temporal changes in PET/FIDESF
The temporal change in the PET/FIDESF was modeled using
an exponential function of time as follows:
Predicted PET/FIDESF=f(time)=Asym+(y0-Asym)×e-elrc×time
where Asym is the asymptote as time approaches infinity,
and y0 is PET/FIDESF at T0. The parameter, lrc, is the logarithm
of the rate constant, ensuring a positive rate constant. The
time to half (t0.5) can be derived from log(2)/e
lrc. The param-
eter time is the elapsed time from T0. PET/FIDESF was fitted as
a function of time, where the covariates, such as N2O, PETCO2,
MAP, HR, and CI, were analyzed to demonstrate their effects
on the individual parameters; Asym, y0, and lrc. The term
for the random effects was constructed initially with the inter-
cepts of Asym, y0, and lrc. Between the random effects, the
high correlations (r>0.9) were removed by under-parameter-
ization. The variance component of the random effects belong-
ing to the subjects was also examined.Desflurane and Cerebral Oximetry 1053
Modeling for the increase in  rSO2 for PETDESF
The rSO2 increased as a function of the logarithm of
PETDESF according to the following equation:
rSO2=f [log(PETDESF)]=Rmax+ R0-Rmax
1+e[log(PETDESF)-LC50]/θ
where Rmax is the maximum response, R0 is the initial res-
ponse, LC50 is the log(PETDESF) value at the inflection point
[=log(EC50)], and θis simply the inverse slope factor. This is
known as the four-parameter logistic model, which relates
the response of  rSO2 to an input PETDESF using a sigmoidal
function. When describing and discussing the results, all the
LC50 was translated in terms of the EC50, eLC50.
The effects of PETCO2 and N2O on the individual model
parameters, Rmax, R0, LC50, and θ , were the primary focus of
this study. The other covariates, MAP, HR and CI, were also
examined using the stepwise including and excluding tech-
nique. The term for the random effects was constructed with
the intercepts of Rmax and θ . No random effects of R0 or LC50
were assumed. The block diagonal matrix was specified to
represent the random effects variance-covariance matrix. The
heteroscedasticity of the within-subject errors, particularly
at low PETDESF levels, was accommodated using a variance
function, which is a power of the absolute value of the vari-
ance covariate.
The final model was chosen based on a log-likelihood test
and an analysis of variance of nonlinear mixed-effects model.
The median (Q1-Q3) standardized residuals were calculated
to determine the quality of the prediction for the population.
The typical values of the overall cerebrovascular reactivity of
rSO2 to CO2 were estimated form (Rmax(40 mmHg)-Rmax(30 mmHg))/
10 mmHg in each group.
Unless specified otherwise, all values are reported as mean
±SD. All statistical analyses, including nonlinear mixed-
effects modeling, inferential statistics, and arithmetic calcu-
lations, were performed using S-Plus 8.0 (Insightful Corp.,
Seattle, WA, U.S.A.), which was enhanced using the nlme
(nonlinear mixed effects) version 3.3.2 library (Pinheiro and
Bates, U.S.A.).Therefore, estimates of the parameters for the
fixed effects of the mixed-effects model are presented as the
mean (standard error of the mean), and the residuals of the
fitted model were presented as the median (Q2-Q3). Random
effects were presented as overall SD of the random effects. Bet-
ween the groups, the basic measurements and calculations
were compared using a Wilcoxon rank test, and the gender
distribution was compared using a Fisher’s exact test. A mul-
tiple Wilcoxon rank test was used with the P′to compare
the pairwise contrasts for the groups at 12 periods. P values
<0.05 were considered significant. 
RESULTS 
Measurements, calculations, and the reliability of the
measurements
There was no significant difference in the basic measure-
ments between the groups (Table 1). There was also no sig-
Values are reported as the mean±SD.
All measurements in the Table 1 show no significant differences bet-
ween the two groups (P≥0.05).
BSA, body surface area, estimated by 71.84×Body Weight
0.425×Height
0.725/
10,000; MAP, mean arterial pressure; HR, heart rate; CO, cardiac output;
CI, cardiac index.
Parameters
Overall
(n=12)
Air group
(n=6)
N2O group
(n=6)
Age (yr) 42±10 45±63 9 ±12
Sex (male/female) 6/6 3/3 3/3
Body weight (kg) 63±10 64±12 62±9
Height (cm) 162±9 160±10 164±9
BSA (m
2) 1.67±0.17 1.67±0.19 1.67±0.17
Hemoglobin (g/dL) 13.8±1.2 13.6±1.2 14.0±1.2
MAP (mmHg) 94±15 90±69 9 ±20
HR (beat/min) 71±12 62±10 71±12
CO (L/min) 5.80±1.67 6.50±1.86 5.10±1.23
CI (L/min/m
2) 3.48±0.95 3.93±1.07 3.03±0.59
Table 1. Summary statistics for the basic measurements and
calculations
Values are reported as the mean±SD (min-max).
Measurements of PETCO2, SpO2, and final PFIDESF in the Table 2 show no
significant difference between the two groups (P≥0.05).
The values of MAP, HR, CO, CI, and PETDESF were not compared based
on the simple mean±SD, which is meaningless.
n, number of total repeated measurements for 6 subjects in each group;
BSA, body surface area; MAP, mean arterial pressure; HR, heart rate;
CO, cardiac output; CI, cardiac index; PETCO2, end-tidal CO2 concentra-
tion; SpO2, pulse oximetry; PETN2O, end-tidal N2O concentration; PFIN2O,
inspired N2O concentration; PETDESF, end-tidal desflurane concentration;
Final PFIDESF, final inspired desflurane concentration.
Parameters
Overall
(n=138)
Air group
(n=67)
N2O group
(n=71)
MAP (mmHg) 74±18 (44-123) 72±20 76±15
HR (beat/min) 81±22 (45-150) 74±16 87±25
CO (L/min) 6.32±2.01 6.02±1.62 6.61±2.29
(2.00-11.90)
CI (L/min/m
2) 3.82±1.32 3.64±1.03 4.00±1.54
(1.35-7.83)
PETCO2 (mmHg) 33±4 (24-41) 33±33 4 ±4
SpO2 (%) 99±1 (98-100) 98±19 9 ±1
PETN2O (%) -- 52±4
PFIN2O (%) -- 53±4
PETDESF (%) 8.9±1.9 9.0±2.0 8.9±1.8
Final PFIDESF (%) 11.5±0.7 11.9±0.9 11.1±0.3
Table 2. Summary statistics for the repeated measurements dur-
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nificant difference in the repeated measurements during rapid
introduction of desflurane between the groups (Table 2). The
mean rSO2 values before and after anesthesia were 68±8%,
whose anesthesia-effect was estimated to be +0-4% but failed
to reach significance at the 5% level (P=0.127). The ρ , esti-
mated intra-class correlation between the two rSO2 measure-
ments was 0.9336, indicating that the repeated measurements
of rSO2 were reliable within-subjects.
Hemodynamic variables
The MAP, HR and CI evenly showed an initial increase
with a subsequent decrease (Fig. 1). The temporal changes
in the MAP, HR, and CI were statistically significant (P<
0.001, P=0.007, and P=0.001, respectively). N2O signifi-
cantly affected the pattern of the temporal changes in the CI
(P=0.021) but not MAP (P=0.059) or HR (P=0.877). Changes
in N2O had no significant effect on the CI at any separate time
period (P′ ≥0.05 between groups). Despite the statistical
insignificance, N2O mildly augmented the increase in the
HR (+17 beats/min), and reduced the slope of the decrease
in the HR, MAP, and CI.
Modeling for the temporal changes in PET/FIDESF
The temporal changes in PET/FIDESF were modeled by
Predicted PET/FIDESF
=f(time)=0.9080+(0.6196-0.9080)×e-e-0.7836×Time
when PETCO2=40 mmHg and CI=3.8 L/min/m2 (Fig. 2).
The time to half (t0.5) was estimated to be approximately 1.5
min from T0. In concordance with the well-known concept
on the pharmacokinetics of volatile anesthetics, the PETCO2
(P=0.001) and CI (P<0.001) significantly modified the Asym,
not lrc or y0. A decrease in PETCO2 increased the Asym by
0.0014 (0.0009, SE)/mmHg and increase the CI by 0.0081
(0.0019, SE)/L/min/m2. No other covariates, such as the N2O,
MAP, or HR, modified the parameters. There was a strong
correlation between the random effects for the intercepts of
Fig. 1. Temporal changes in the MAP (upper panel), HR (middle
panel) and CI (lower panel). During rapid introduction of desflu-
rane, MAP, HR, and CI show consistent initial increase (near 30%,
1.5 min) and a subsequent decrease. N2O does not blunt these
increases, and modifies the temporal pattern of the change in CI
significantly* (P=0.021) regardless of there being no significant
difference at any time period by multiple comparisons (P′ ≥0.05).
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Asym and y0 (r=0.983) and random effects for y0 were re-
moved. Random effects were ±0.0458. The standardized
residuals were normally distributed, -0.1803 (-0.7387-0.5468). 
Modeling for the increase in  rSO2 for PETDESF
The final model for the increase in  rSO2 were determined
using the following equation 
Predicted rSO2=f[log(PETDESF)]
=25.9425+ -0.3362-25.9425
1+e[log(PETDESF-40)-9.3549]/0.1084
where PETCO2=40 mmHg in the Air group. In the model,
R0was constant at -0.3362 (0.2894) and Rmax, EC50 and θwere
modified by a combination of PETCO2 and N2O (Table 3). No
other covariates, such as MAP, HR, or CI, had a significant
effect on the parameters (P≥0.05). The effects of CO2 on
Rmax and θwere estimated within the course of the increase
in PETDESF (Fig. 3). However, the typical values for the cere-
brovascular reactivity to CO2 could be estimated by 1.5389%/
mmHg in the Air group, and 1.2898%/mmHg in the N2O
group (P≥0.05 between groups). Random effects were ±
2.3872. The standardized residuals were normally distribut-
ed, 0.1798 (-0.4629-0.4713).
DISCUSSION 
During the rapid introduction of desflurane, the curve for
the temporal increase in PET/FIDESF from a concentration of
4% to 12% in this study agreed reasonably well with a text-
book example regarding the effect of PETCO2 and CI. High
residuals are indicative of low predictability and the need of
the two-exponential curves. We did not attempt to refine the
model because it was beyond the interest of the present study.
Prefilled N2O in the lung had no effect on the curve. The
rapid introduction of desflurane produced a similar hemody-
namic stimulatory effects to previous reports. Stimulation
peaked at approximately 1.5 min from T0, which approxi-
mated to t0.5 of the curve for the increase in PET/FIDESF. N2O
failed to block the stimulation of MAP and HR, or mildly
promoted the increased pattern, which is comparable to the
N2O-induced changes in pupil diameter reported by Daniel
et al. (3). As expected, rSO2 also increased up to 24-25% ac-
cording to the increase in PETDESF in a concentration-depen-
dent manner. The residuals were extremely small and inde-
pendent of any possible violation by the MAP, HR, or CI.
This study did not examine the random effects in detail. The
Values are reported as the mean (standard error of mean).
Rmax, the destined maximum response of rSO2; EC50, median effective
concentration of desflurane, e
LC50; θ , the inverse slope factor; PETCO2, end-
tidal concentration of carbon dioxide.
The * mark denotes the statistically significant difference from PETCO2=40
mmHg (P<0.001); The 
�mark denotes the statistically significant differ-
ence from Air group (P<0.001).
Groups Rmax (%) EC50 (%) θ
Air group (n=6)
PETCO2=40 mmHg 25.9425  9.3549 0.1084 
(4.6705) (1.0516) (0.0252)
PETCO2=30 mmHg 10.5571  9.4348 0.0276 
(1.7997)* (1.0359)* (0.0083)*
N2O group (n=6)
PETCO2=40 mmHg 24.8791 10.0976 0.1851
(4.6705) (1.0070)
� (0.0245)
�
PETCO2=30 mmHg 11.9812 9.4565 0.0276
(1.7997)* (0.0359)* (0.0083)*
Table 3. Parameter estimates of the model to fit  rSO2 accord-
ing to PETCO2
Fig. 3. Predicted rSO2 for the increase in PET/FIDESF according to the change in PETCO2. The predicted  rSO2 increases with increasing
PETDESF as a four-parameter logistic curve. At PETCO2=40 mmHg, the addition of N2O decreases the slope of the increase, but the same maxi-
mum rSO2 lies outside of this graph. In N2O group, both the inverse slope factor and maximum rSO2 decrease significantly with decreas-
ing PETCO2. The N2O-effects decrease with decreasing PETCO2, and the differences between the groups disappear when PETCO2= 30 mmHg. 
PETDESF, end-tidal concentration of desflurane (%); PETCO2, end-tidal carbon dioxide concentration (mmHg). 
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random effects were confined to refining the relationship bet-
ween the predictors and the response by eliminating the indi-
vidual variability. Modeling for the population was beyond
the scope of this study. The fitted equation included three
major parameters, Rmax, EC50, and θ .
Hypocapnia reduced the Rmax, and increased the slope in
the Air group. EC50 was shifted to the right slightly but sig-
nificantly. This suggests that the cerebrovascular reactivity
to CO2 still subsists at more than 1.5 MAC desflurane. The
CO2 reactivity was not measured while the patient was awake.
Therefore, the absolute values for the reactivity cannot be used
to draw any real conclusion as to whether it was intact or pre-
served. There are no reports on the reactivity to CO2 measured
at high concentrations of desflurane that could be used to
compare with the present study. With 0.5-1.0 MAC desflu-
rane, the reactivity to CO2 is considered to be preserved (7-
9). In a study of 1.5 age-adjusted MAC desflurane-anesthe-
tized children, the reactivity to CO2 was impaired (8). The
estimate of the overall reactivity to CO2 of rSO2 was 1.2898-
1.5389%/mmHg, which is similar to the 1.1±0.67%/
mmHg estimated results from 5% desflurane-anesthetized
adults by Lee et al. (9). In this study, the reactivity to CO2
was estimated during the dynamic phase of the increasing
concentration of desflurane, which is unlike the steady state
used by others. Its importance is unknown and so any com-
parison might be invalid.
Although there is some discrepancy in the measurements or
design, it can be generally summarized that the cerebrovascular
effect of the solitary or additional N2O to volatile anesthetics
causes an elevation (10-12), or at least no decrease (13-16) in
the cerebral blood flow. Interpreting the effect of N2O on these
parameters is quite complicated. During normocapnia, the
addition of 60% N2O obviously increased the inverse slope
factor θand shifted EC50 to the right in order to reduce the
change in rSO2 caused by an increase in desflurane concentra-
tion, while the Rmax was unchanged. These N2O-effects dis-
appeared in hypocapnia. Lowering PETCO2 shifted the EC50 to
the left and reduced the θ s. Summary of the hypocapnia-effect
in the N2O group is the right-shift and steepening of the curve.
There may be two explanations for this observation. The rapid
introduction of desflurane could cause a pronounced hyper-
emic condition of the brain, in which no more hyperemia could
be reached even by adding N2O. The slower response in the
N2O group might indicate a disturbance of the cerebral vascu-
latures to changes in the desflurane concentration. The other
explanation is that hypocapnia overwhelms the effect of N2O.
The former explanation partly agrees with some previous
studies that reported a cerebrovascular effect in anesthesia
with a combination of N2O and volatile anesthetics, in which
N2O had no additional effect on the volatile-induced change
in cerebral blood flow velocity (16). Contradiction was also
found. For example, N2O disturbs the flow/metabolism cou-
pling when added to sevoflurane (12). No other report has
estimated the additional N2O-effect even with a desflurane
concentration of >1.5 MAC or with a variety of CO2 tension.
The latter explanation remains to be demonstrated. There
are no reports of interactions between hypocapnia and N2O.
Local factors of the brain should also be considered. N2O or
volatile anesthetics redistribute rCBF (13, 17, 18). The rSO2
measurements were limited to the frontal pole of the brain,
which represent neither the global CBF nor typical rCBF. 
One limitation of this study is that the protocol included
3 ng/mL Ce of remifentanil during induction of anesthesia.
It was clinically relevant to suppress the hemodynamic res-
ponse due to laryngoscopy. By waiting 20 min from the dis-
continuation of the remifentanil infusion, it was confirmed
the Ce fell below 0.3 ng/mL. This is the minimum concentra-
tion where no hemodynamic interaction between remifentanil
and desflurane would be expected. Moreover, our episodic
finding suggested that desflurane-induced sympathetic stim-
ulation is unlikely repeat once it was stimulated, which was
also inferred from the classical report by Weiskopf et al. (19).
Another shortcoming of this study is the well-known lim-
itations of rSO2. It is believed that the confounders had been
eliminated. The hemoglobin concentrations and PETCO2 values
were similar in both groups, which would be regarded a major
determinant for the change in rSO2. The SpO2 values were all
within 98-100%, and the MAP values were within 44-123
mmHg. Only two subjects showed a MAP <50 mmHg. The
within-subject variability was confirmed to be <10% with
the reliability test using the intra-class correlation. The value
of the intra-class correlation in examining the reliability of
the repeated medical data was well described by Everitt and
Rabe-Hesketh (20). The inter-subjects variability of rSO2 was
also removed by considering the difference from the baseline.
There was a relatively small number of subjects enrolled in
this study. However, the nature of mixed-effects modeling
can overcome the size of the sample. The limitations related
to the small sample size always arise from the inevitable inter-
individual variability, which can be eliminated by mixed-effects
modeling. The quality of our fitted model was exceptionally
good, and the results and conclusions are strong.
In conclusion, a nonlinear mixed-effects model, which st-
rongly predicted the response of rSO2 as the function of log-
arithm concentration of PETDESF, was modified only by PETCO2
and N2O. Hypocapnia shifted the response curve to the right
and reduced the maximum response of rSO2in the Air group.
The cerebrovascular reactivity to CO2 still preserved within
the scope of this study. It is difficult to interpret the effects
of N2O on the response of rSO2 to the rapid introduction of
desflurane. There are little or no N2O-induced hemodynam-
ic changes and the effects of N2O are definitely due to its in-
herent cerebrovascular effect. 
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